Amgen Plans 2017 Filings After Second Phase III CGRP Inhibitor Success

 
• By Mandy Jackson
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D